[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567769":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":23,"locations":31,"responsibleParty":54,"collaborators":57,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":64,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":79,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University of South Carolina","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients diagnosed with breast or gynecological cancer and undergoing neoadjuvant chemotherapy.",null,"Females ages 20...",[13,17,20],{"name":14,"affiliation":15,"role":16},"Jennifer L Trilk, PhD","University of South Carolina School of Medicine, Greenville","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":19,"role":16},"Randolph Hutchison, PhD","Furman University",{"name":21,"affiliation":22,"role":16},"Larry Gluck, MD","Prisma Health",[24,28],{"name":14,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","864-455-1410","trilk@greenvillemed.sc.edu",{"name":29,"role":25,"phone":26,"phoneExt":10,"email":30},"Frankie Bennett, MS","bennet24@greenvillemed.sc.edu",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Prisma Health Cancer Institute","RECRUITING","Greenville","South Carolina","29605","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-82.39401,34.85262,{"lat":44,"lon":43},[47,48,51,52,53],{"name":29,"role":25,"phone":26,"phoneExt":10,"email":30},{"name":49,"role":25,"phone":26,"phoneExt":10,"email":50},"James Rosemeyer, MS","rosemeyj@greenvillemed.sc.edu",{"name":14,"role":16,"phone":10,"phoneExt":10,"email":10},{"name":18,"role":16,"phone":10,"phoneExt":10,"email":10},{"name":21,"role":16,"phone":10,"phoneExt":10,"email":10},{"type":16,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Jennifer Trilk","Professor of Biomedical Sciences and Director of the Human Performance Lab",[58,60],{"name":19,"class":59},"UNKNOWN",{"name":61,"class":6},"Prisma Health-Upstate","100567769","near-infrared-spectroscopy-nirs-as-a-method-for-measuring-oxidative-capacity-of-skeletal-muscle-mitochondria-in-breast-cancer-and-all-gynecological-cancer-patients-100567769",false,"NCT06672497","Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients","Inclusion Criteria:\n\n* Patients diagnosed with breast cancer or gynecological cancer without distance metastasis\n* Able to perform exercise on a stationary cycle ergometer at moderate intensities for a maximum of 15 minutes\n* Hemoglobin values greater than 10 at baseline\n* ALT and AST values less than 2.5X the upper limit of normal by institutional standards\n* Godin-Shepard Leisure time Physical Activity Questionnaire (GLTEQ) score of 14 or greater will be included. A score of less than 14 is considered insufficiency active\u002Fsedentary\n\nExclusion Criteria:\n\n* Metastatic breast or gynecological cancer\n* Clinically advanced cardiovascular disease\n* Clinically advanced pulmonary disease\n* Disease requiring continuous oxygen supplementation\n* Greater than 2 centimeters or more of subcutaneous adipose tissue on the anterior thigh\n* Inability to walk or stand\n* Movement disorders\n* Spinal cord injuries\n* Autoimmune disorders\n* Pregnant or breastfeeding\n* Mini-Mental State Examination (MMSE) \\\u003C24","FEMALE","20 Years",{"count":71,"type":72},30,"ESTIMATED","OBSERVATIONAL","Participants recruited for this study will be breast cancer or gynecological cancer patients who agree to participate in an exercise study examining the effects of chemotherapy on muscle mitochondrial oxidative capacity, a measure of skeletal muscle health. Participants will ride a stationary bicycle and the quadriceps muscle will be non-invasively evaluated.",[76,77,78],"Breast Cancer","Gynecologic Cancers","Mitochondrial Function",[80,81,82,83,84,85],"nirs","mitochondrial oxidative capacity","muscle oxidative capacity","breast cancer","gynecological cancer","near infrared spectroscopy","2024-11-01",{"date":88,"type":89},"2024-11-04","ACTUAL",{"date":91,"type":89},"2021-09-07",{"date":93,"type":72},"2026-03",{"name":5,"class":6},1]